Viewing Study NCT03681951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-21 @ 6:10 AM
Study NCT ID: NCT03681951
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2018-09-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Pancreatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anticancer Agents View
None FTIH View
None Pembrolizumab View
None Rip1K View
None GSK3145095 View
None Dose Escalation View
None Immunotherapy resistance View
None Dose Expansion View
None RECIST 1.1 View
None Advanced solid tumors View
None Innate immunity View